| Product Name | MF | CAS | Details |
|---|
| 4-(trifluoromethyl)nicotinic acid | C7H4F3NO2 | 158063-66-2 | Details |
| Afatinib Impurity A | Details |
| Afatinib Impurity D | Details |
| Afatinib Impurity C | Details |
| Afatinib Impurity E | Details |
| Afatinib Impurity F | Details |
| Alogliptin Impurity 10 | Details |
| Afatinib Impurity H | Details |
| Alogliptin Impurity 3 | Details |
| Alogliptin Impurity 1 | Details |
| Afatinib Impurity I | C22H19BrClFN4O3 | 1637254-93-3 | Details |
| Alogliptin Impurity 2 | Details |
| Afatinib Impurity J | C18H22N4O4 | 1456696-14-2 | Details |
| Afatinib Impurity G | Details |
| Rivaroxaban Impurity E | C7H8ClNOS | 88777-57-5 | Details |
| Rivaroxaban Impurity A | C19H19N3O5S | 1415566-28-7 | Details |
| Dacomitinib | C24H25ClFN5O2 | 1110813-31-4 | Details |
| Alogliptin Impurity 4 | Details |
| Alogliptin Impurity 7 | Details |
| Crisaborole | C14H10BNO3 | 906673-24-3 | Details |
| Rivaroxaban Impurity C | C29H32N6O9 | 1365267-35-1 | Details |
| Alogliptin Impurity 5 | Details |
| Alogliptin Impurity 8 | Details |
| R-afatinib | C24H25ClFN5O3 | 945553-91-3 | Details |
| Alogliptin Impurity 9 | Details |
| N-((1S)-1-(1-Naphthyl)ethyl)-3-(3-(trifluoromethyl)phenyl)propan-1-amine | C22H22F3N | 694495-47-1 | Details |
| Rivaroxaban Impurity D | C6H6ClNOS | 97799-98-9 | Details |
| Alogliptin Impurity 6 | Details |
| Rivaroxaban Impurity F | C9H7NO2 | 550-44-7 | Details |
| N-Cyanomethyl-4-trifluoromethyl-3-pyridinecarboxamide | C9H6F3N3O | 158062-67-0 | Details |
| vandetanib | C22H24BrFN4O2 | 443913-73-3 | Details |
| R-Rivaroxaban | C19H18ClN3O5S | 865479-71-6 | Details |
| Ibrutinib | C25H24N6O2 | 936563-96-1 | Details |
| Rivaroxaban Impurity H | C25H24Cl2N4O6S2 | 1807455-76-0 | Details |
| Mubritinib | C25H23F3N4O2 | 366017-09-6 | Details |
| Afatinib dimaleate | C28H29ClFN5O7 | 850140-73-7 | Details |
| 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide,hydrate,hydrochloride | C28H25ClF3N7O2 | 923288-90-8 | Details |
| N-(2-Chloro-6-methylphenyl)-2-[(6-chloro-2-methyl-4-pyrimidinyl)amino]-5-thiazolecarboxamide | C16H13Cl2N5OS | 302964-08-5 | Details |
| 4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide | C28H22F3N7O | 641571-10-0 | Details |
| SILYBIN | C25H22O10 | 22888-70-6 | Details |
| 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzoic acid | C17H14N4O2 | 641569-94-0 | Details |
| Afatinib | C24H25ClFN5O3 | 850140-72-6 | Details |
| Rivaroxaban Impurity L | Details |
| Rivaroxaban Impurity J | C24H21Cl2N3O7S2 | 1151893-81-0 | Details |
| Afatinib Impurity B | C18H16ClFN4O2 | 314771-76-1 | Details |
| Rivaroxaban Impurity G | C18H20ClN3O4S | 721401-53-2 | Details |
| 7-Hydroxy-6-methoxy-3,4-dihydroquinazolin-4-one | C9H8N2O3 | 162012-72-8 | Details |
| S-Alogliptin | Details |
| 3-(trifluoromethyl)-5-(4-methyl-1H-imidazol-1-yl)benzenamine | C11H10F3N3 | 641571-11-1 | Details |
| Rivaroxaban Impurity I | C10H12N2O2 | 1082495-22-4 | Details |
| Rivaroxaban Impurity K | Details |
| Rivaroxaban Impurity M | C11H9NO3 | 181140-34-1 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||